Original Research

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer

Abdel Kader Y, Spielmann M, El-Nahas T, Sakr A, Metwally H

Breast Cancer: Targets and Therapy 2013, 5:37-42

Published Date: 17 June 2013